A New Enzyme Mixture to Increase the Yield and Transplant Rate of Autologous and Allogeneic Human Islet Products
2012 · Transplantation · 119 citations
https://doi.org/10.1097/tp.0b013e318247281b
T
Takeshi Yuasa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
528
Papers
8.6K
Citations
45
h-index
177
i10-index
Takeshi Yuasa is an academic researcher from Japanese Foundation For Cancer Research. The author has contributed to research in topics: Renal cell carcinoma treatment & Bladder and Urothelial Cancer Treatments & Cancer Genomics and Diagnostics. The author has an h-index of 45, co-authored 449 publications.
ORCID: 0000-0002-8924-6730Papers by this author
worksFirst-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
2014 · British Journal of Cancer · 70 citations
https://doi.org/10.1038/bjc.2014.25
Biomarkers to predict prognosis and response to checkpoint inhibitors
2017 · International Journal of Clinical Oncology · 65 citations
https://doi.org/10.1007/s10147-017-1122-1
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium
2020 · European Urology Oncology · 57 citations
https://doi.org/10.1016/j.euo.2020.01.001
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas
2016 · Scientific Reports · 34 citations
https://doi.org/10.1038/srep25669
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
2006 · British Journal of Cancer · 31 citations
https://doi.org/10.1038/sj.bjc.6603423
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat